🇺🇸 FDA
Patent

US 9107940

Compositions and methods for treating and preventing skeletal muscle deficiencies

granted A61KA61K31/765A61K45/06

Quick answer

US patent 9107940 (Compositions and methods for treating and preventing skeletal muscle deficiencies) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/765, A61K45/06, A61P, A61P19/04